These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25571472)

  • 21. Can renal biopsy accurately predict histological subtype and Fuhrman grade of renal cell carcinoma?
    Millet I; Curros F; Serre I; Taourel P; Thuret R
    J Urol; 2012 Nov; 188(5):1690-4. PubMed ID: 22998910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of renal tumour biopsy for the diagnosis and subtyping of papillary renal cell carcinoma: analysis of paired biopsy and nephrectomy specimens with focus on discordant cases.
    Prendeville S; Richard PO; Jewett MAS; Kachura JR; Sweet JM; van der Kwast TH; Cheung CC; Finelli A; Evans AJ
    J Clin Pathol; 2019 May; 72(5):363-367. PubMed ID: 30755496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and validation of an eight-gene expression signature for predicting high Fuhrman grade renal cell carcinoma.
    Wan F; Zhu Y; Han C; Xu Q; Wu J; Dai B; Zhang H; Shi G; Gu W; Ye D
    Int J Cancer; 2017 Mar; 140(5):1199-1208. PubMed ID: 27874173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.
    Lang H; Lindner V; de Fromont M; Molinié V; Letourneux H; Meyer N; Martin M; Jacqmin D
    Cancer; 2005 Feb; 103(3):625-9. PubMed ID: 15611969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Grading of renal cell carcinoma.
    Goldstein NS
    Urol Clin North Am; 1999 Aug; 26(3):637-42, vii. PubMed ID: 10494294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal structural image processing techniques: a systematic review.
    Asadzadeh S; Khosroshahi HT; Abedi B; Ghasemi Y; Meshgini S
    Ren Fail; 2019 Nov; 41(1):57-68. PubMed ID: 30747036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CT-based machine learning model to predict the Fuhrman nuclear grade of clear cell renal cell carcinoma.
    Lin F; Cui EM; Lei Y; Luo LP
    Abdom Radiol (NY); 2019 Jul; 44(7):2528-2534. PubMed ID: 30919041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automated Renal Cancer Grading Using Nuclear Pleomorphic Patterns.
    Holdbrook DA; Singh M; Choudhury Y; Kalaw EM; Koh V; Tan HS; Kanesvaran R; Tan PH; Peng JYS; Tan MH; Lee HK
    JCO Clin Cancer Inform; 2018 Dec; 2():1-12. PubMed ID: 30652593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CT texture analysis: a potential tool for predicting the Fuhrman grade of clear-cell renal carcinoma.
    Feng Z; Shen Q; Li Y; Hu Z
    Cancer Imaging; 2019 Feb; 19(1):6. PubMed ID: 30728073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnosis and management of complex renal cysts.
    McGuire BB; Fitzpatrick JM
    Curr Opin Urol; 2010 Sep; 20(5):349-54. PubMed ID: 20592611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma.
    Sun M; Lughezzani G; Jeldres C; Isbarn H; Shariat SF; Arjane P; Widmer H; Pharand D; Latour M; Perrotte P; Patard JJ; Karakiewicz PI
    Eur Urol; 2009 Nov; 56(5):775-81. PubMed ID: 19573980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can diffusion-weighted magnetic resonance imaging of clear cell renal carcinoma predict low from high nuclear grade tumors.
    Parada Villavicencio C; Mc Carthy RJ; Miller FH
    Abdom Radiol (NY); 2017 Apr; 42(4):1241-1249. PubMed ID: 27904923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of CT imaging features and tumor size with Fuhrman grade of clear cell renal cell carcinoma.
    Oh S; Sung DJ; Yang KS; Sim KC; Han NY; Park BJ; Kim MJ; Cho SB
    Acta Radiol; 2017 Mar; 58(3):376-384. PubMed ID: 27235451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytohistological study of clear cell carcinoma of kidney with special reference to nuclear grading and tumor size.
    Mondal SK
    Diagn Cytopathol; 2012 Dec; 40(12):1083-7. PubMed ID: 21563327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system.
    Montironi R; Santinelli A; Pomante R; Mazzucchelli R; Colanzi P; Filho AL; Scarpelli M
    Virchows Arch; 2000 Jul; 437(1):82-9. PubMed ID: 10963384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases.
    Abel EJ; Carrasco A; Culp SH; Matin SF; Tamboli P; Tannir NM; Wood CG
    BJU Int; 2012 Dec; 110(11):1742-6. PubMed ID: 22503066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and classification of renal cell carcinoma.
    Bostwick DG; Eble JN
    Urol Clin North Am; 1999 Aug; 26(3):627-35. PubMed ID: 10494293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of perinephric fat surface area and Mayo Adhesive Probability score in predicting malignancy in T1 renal masses.
    Bernstein AP; Fram EB; Sankin A; Kovac E; Srivastava A; DiVito J; Stern JM
    Urol Oncol; 2018 Nov; 36(11):499.e17-499.e22. PubMed ID: 30166240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful grading of renal-cell carcinoma in fine-needle aspirates.
    Al Nazer M; Mourad WA
    Diagn Cytopathol; 2000 Apr; 22(4):223-6. PubMed ID: 10787141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.